PMDA publishes FY2025 survey results on drug safety information use at medical institutions
令和7年度「医療機関等における医薬品安全性情報の入手・伝達・活用状況等に関する調査」の調査結果を掲載しました
Published: 2026-03-25 · Source: Pharmaceuticals and Medical Devices Agency (PMDA) — Safety Updates · Stage: Government Announcement · Area: Healthcare / Pharmaceuticals · Impact (preliminary): Low · First detected by this dashboard: 2026-08-06
View the original Japanese source More Healthcare / Pharmaceuticals updates Search all updates in the dashboard
AI summary
Generated by AI from the Japanese source metadata. It is an unofficial monitoring aid, not legal advice, and may contain errors. The area, stage, and impact labels are preliminary keyword-based triage labels. Confirm every point in the original Japanese source.
Summary
On 2026-03-25, the Pharmaceuticals and Medical Devices Agency (PMDA) announced publication of its FY2025 survey results on how medical institutions and similar facilities obtain, communicate and use drug safety information. This is a survey-results announcement, not an announcement of a legislative change.
Business Impact
Medical institutions and similar facilities may find the results relevant to reviewing how they obtain, communicate and use drug safety information, although the findings are not provided in the available title.
Recommended Action
Reviewing the official PMDA survey results could clarify the findings and their relevance to drug safety information practices at medical institutions and similar facilities.